Cell Reports (Oct 2018)

Salt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension

  • Saroj Chakraborty,
  • Sarah Galla,
  • Xi Cheng,
  • Ji-Youn Yeo,
  • Blair Mell,
  • Vishal Singh,
  • BengSan Yeoh,
  • Piu Saha,
  • Anna V. Mathew,
  • Matam Vijay-Kumar,
  • Bina Joe

Journal volume & issue
Vol. 25, no. 3
pp. 677 – 689.e4

Abstract

Read online

Summary: Dietary salt reduction and exercise are lifestyle modifications for salt-sensitive hypertensives. While exercise has prominent metabolic effects, salt has an adverse effect on metabolic syndrome, of which hypertension is a hallmark. We hypothesized that dietary salt impacts metabolism in a salt-sensitive model of hypertension. An untargeted metabolomic approach demonstrates lower circulating levels of the ketone body, beta-hydroxybutyrate (βOHB), in high salt-fed hypertensive rats. Despite the high salt intake, specific rescue of βOHB levels by nutritional supplementation of its precursor, 1,3-butanediol, attenuates hypertension and protects kidney function. This beneficial effect of βOHB was likely independent of gut-microbiotal and Th17-mediated effects of salt and instead facilitated by βOHB inhibiting the renal Nlrp3 inflammasome. The juxtaposed effects of dietary salt and exercise on salt-sensitive hypertension, which decrease and increase βOHB respectively, indicate that nutritional supplementation of a precursor of βOHB provides a similar benefit to salt-sensitive hypertension as exercise. : Chakraborty et al. report a link between dietary salt, a ketone, and experimental hypertension. Intake of a high salt diet lowers the ketone body beta-hydroxybutyrate (βOHB), produced by the liver, which functions to prevent Nlrp3-mediated kidney inflammation. Rescuing βOHB by nutritional supplementation of its precursor attenuates hypertension. Keywords: hypertension, metabolomics, ketone body, salt, blood pressure, β-hydroxybutyrate, inflammation, Nlrp3, inflammasome, kidney